COVID-19 is testing the supply chain and manufacturing operations around the world. Companies have their hands full dealing with workers who have become ill or those who are required to be home because of school closings due to lack of raw materials delivery and limited work hours. Now more than ever, businesses are evaluating how to improve efficiency, lower cost, and increase operational performance. The immediate question on everyone’s mind is, “how are we coming out of this crisis”?

The impact of the COVID-19 pandemic has created a new milestone in market dynamics, forever changing the face of the global economy. Along with the pandemic’s impact on our daily lives, there has been a ripple effect in the day-to-day operations of Pharmaceutical manufacturing. As industries around the world continue to adjust to changes, Pharmaceutical manufacturers in specific, are noticing technology, process, and infrastructure gaps that are impeding growth and sustainability. Additionally, businesses that were forced to slow production during the initial stages of COVID-19 and are now getting back to full production are finding it difficult to regain momentum in end-to-end operations.